Kyntra Bio (KYNB) Change in Cash (2014 - 2026)

Kyntra Bio has reported Change in Cash for 13 years, with the latest figure at -$10.9 million in Q1 2026.

• Quarterly Change in Cash fell 370.39% year-over-year to -$10.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $33.0 million (up 6976.18% YoY) and the FY2025 annual result came in at $47.9 million, up 515.92% from the prior year.
• Change in Cash eased to -$10.9 million in Q1 2026 per KYNB's latest filing, from $32.1 million in the prior quarter.
• Over five years, Change in Cash peaked at $35.0 million in Q2 2024 and troughed at -$36.0 million in Q2 2023.
• A 5-year average of -$1.9 million and a median of -$7.2 million in 2023 frame the typical range for Change in Cash.
• The sharpest annual moves came in 2023 and 2025: Change in Cash tumbled 2679.23% in 2023, then jumped 211.27% in 2025.
• Over 5 years, Change in Cash stood at -$260000.0 in 2022, then sank by 2679.23% to -$7.2 million in 2023, then plunged by 298.91% to -$28.8 million in 2024, then surged by 211.27% to $32.1 million in 2025, then sank by 133.9% to -$10.9 million in 2026.
• According to Business Quant data, Change in Cash over the past three periods registered -$10.9 million, $32.1 million, and -$1.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.